Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record

Enrolling by invitationPhase 4MS (type not specified)NCT02670161

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)

What it measured

Main measures

  • survival free of discontinuation or alternative prevention drug (migraine trial)

    six months

  • survival free of disability measured by FAQ score 9+ (memory trial)

    one year

    Thinking and memory
  • survival free of discontinuation or alternative anti epileptic drug (epilepsy trial)

    one year

Who could take part

MS (type not specified) · 18 to 100

Show the full criteria

Inclusion criteria

* Diagnosis of brain tumors, epilepsy, migraine, mild cognitive impairment (concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, and stroke. * Eligible to receive any of the three compared treatments according to FDA approval for the indication or off label use according to standard of care.

Exclusion criteria

-- None

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.

Papers

Loading reviews and guidelines…

History

    1. Started

      May 2016

    2. Main results due

      Dec 2026

    3. Finished

      Dec 2027

    Assembled by software from public sources.